logo

Purchase of Nanobodies and epitope mapping for grant funded project

Sector: Commercial • Location: United Kingdom

Source: Open Contracting Data Standard (OCDS)

Tender
Complete

The very important time constrains (before 20th of March 2026) attached to the awarded grant finance, for our specific objective, This supplier expertise with expressing our nanobody sequences in different formats, their speed, competitive pricing and MHRA’s prior in house validation of nanobody products made by this supplier , makes this supplier in our view the only provider that can realistica

Status
Closed
Sector
Commercial
Location
United Kingdom
Updated
3 Nov 2026
Source
Open Contracting Data Standard (OCDS)

ConstructChat

Ask ConstructChat about Purchase of Nanobodies and epitope mapping for grant funded project

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Purchase of Nanobodies and epitope mapping for grant funded project” is a tender record in Taiyo, linked to the Commercial sector. It is issued for works, goods, or services related to United Kingdom.

Participants

Not available for this record.

Status

Original status

complete

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

The very important time constrains (before 20th of March 2026) attached to the awarded grant finance, for our specific objective, This supplier expertise with expressing our nanobody sequences in different formats, their speed, competitive pricing and MHRA’s prior in house validation of nanobody products made by this supplier , makes this supplier in our view the only provider that can realistically meet our request within the allocated timelines. Protein production can be outsourced from several commercial entities, but the trade for companies that have relevant and ample experience in nanobody expression, at small scale, in a cost-effective and time-saving manner to fulfil our request is limited. Further, the timeline to complete the objectives of the project with the awarded grant finance translates into the inability to search, outsource, trial and validate the suitability of nanobodies produced by other suppliers unknown to MHRA, significantly narrowing feasible possibilities.

Location

Country

United Kingdom (UK)

Source

Source

Open Contracting Data Standard (OCDS)

URL

More Details

Record type

Tender

Sector

Commercial

Article published date

2026-03-16

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender